| Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium DA Gorog, RF Storey, PA Gurbel, US Tantry, JS Berger, MY Chan, ... Nature Reviews Cardiology 19 (7), 475-495, 2022 | 268 | 2022 |
| Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment A Gąsecka, JA Borovac, RA Guerreiro, M Giustozzi, W Parker, D Caldeira, ... Cardiovascular drugs and therapy 35, 215-229, 2021 | 174 | 2021 |
| Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment M Giustozzi, H Ehrlinder, D Bongiovanni, JA Borovac, RA Guerreiro, ... Blood reviews 50, 100864, 2021 | 116 | 2021 |
| Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease RC Orme, WAE Parker, MR Thomas, HM Judge, K Baster, W Sumaya, ... Circulation 138 (13), 1290-1300, 2018 | 92 | 2018 |
| International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature JJ Maguire, WAE Parker, SM Foord, TI Bonner, RR Neubig, AP Davenport Pharmacological reviews 61 (1), 1-8, 2009 | 68 | 2009 |
| Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and … WAE Parker, C Schulte, T Barwari, F Phoenix, SM Pearson, M Mayr, ... Cardiovascular diabetology 19, 1-13, 2020 | 39 | 2020 |
| Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54 WAE Parker, RF Storey Heart 102 (10), 783-789, 2016 | 39 | 2016 |
| Ticagrelor: clinical development and future potential NC Sanderson, WAE Parker, RF Storey Reviews in Cardiovascular Medicine 22 (2), 373-394, 2021 | 37 | 2021 |
| Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome WAE Parker, RC Orme, J Hanson, HM Stokes, CM Bridge, PA Shaw, ... Platelets 30 (2), 148-157, 2019 | 32 | 2019 |
| Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature WAE Parker, O Edafe, SP Balasubramanian Pragmatic and Observational Research, 57-67, 2017 | 32 | 2017 |
| Pharmacodynamic effects of a 6-hour regimen of enoxaparin in patients undergoing primary percutaneous coronary intervention (PENNY PCI Study) W Sumaya, WAE Parker, R Fretwell, IR Hall, DS Barmby, JD Richardson, ... Thrombosis and haemostasis 118 (07), 1250-1256, 2018 | 27 | 2018 |
| Antithrombotic therapy for patients with chronic coronary syndromes WAE Parker, RF Storey Heart 107 (11), 925-933, 2021 | 26 | 2021 |
| Novel approaches to P2Y12 inhibition and aspirin dosing WAE Parker, RF Storey Platelets 32 (1), 7-14, 2021 | 19 | 2021 |
| Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study WA Parker, DL Bhatt, J Prats, JRS Day, PG Steg, GW Stone, CW Hamm, ... Thrombosis and haemostasis 117 (06), 1093-1100, 2017 | 18 | 2017 |
| New antithrombotic drugs in acute coronary syndrome B Zwart, WAE Parker, RF Storey Journal of clinical medicine 9 (7), 2059, 2020 | 17 | 2020 |
| Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist WAE Parker, RF Storey Expert Opinion on Emerging Drugs 25 (1), 1-6, 2020 | 16 | 2020 |
| Blood coagulation disorders in heart failure: from basic science to clinical perspectives A Siniarski, A Gąsecka, JA Borovac, PE Papakonstantinou, ... Journal of cardiac failure 29 (4), 517-526, 2023 | 15 | 2023 |
| Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy TA Nelson, WAE Parker, T Ghukasyan Lakic, J Westerbergh, SK James, ... Platelets 33 (3), 425-431, 2022 | 15 | 2022 |
| Comparison of contemporary drug-eluting coronary stents–is any stent better than the others? W Parker, J Iqbal Heart International 14 (1), 34, 2020 | 15 | 2020 |
| Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary … BW Hennigan, R Good, C Adamson, WAE Parker, L Martin, L Anderson, ... Platelets 33 (1), 141-146, 2022 | 13 | 2022 |
